SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (157)2/3/1998 9:48:00 AM
From: Larry Liebman  Read Replies (1) | Respond to of 399
 
It is always interesting when someone posts their fantasies of how duplicitous and corrupt a company is imagined to be. Of course, you are aware that we need to immediately short Pharmacia, American Home, Roche, Monsanto, etc. Where are people doing their research?



To: Dr. John M. de Castro who wrote (157)2/3/1998 1:35:00 PM
From: ahhaha  Read Replies (1) | Respond to of 399
 
About ABT. Time to sell. It's over owned, overblown, and ready to start the long downside. No, not quite ready. It'll take a few months of general topping before the experts realize, "oh my god, get me out!" If you own them you should take advantage of the topping process and sell.

You believe in authority because that's part of your livelihood. You have no idea why ABT is throwing peanuts at ARQL. I suggest they are doing it for its speculative potential. It's the same kind of reasoning that you have been making for ARQL for the last six months. A little dough to run the prayer wheel faster might accidentally hit on something ABT can use. There's a little juice in it for ARQL, but you can't expect this kid of strategy to generate a reliable stream of future income.That's like asserting that martingale's have a positive expected return.

You stated some months ago that this company has little downside risk and great upside potential, so effectively they can't lose. The nature of markets is such that the best knowledge available implies that instantaneous expectations are fully reflected in current price. Either your assessment characterization is incorrect in that upside and downside at any instant are in equilibrium or you know more than all the other experts who fully understand the technology of this company. The latter may be true, but I'd never make that kind of outlandish claim, because it gets you psychologically bagged. That means you're hooked and hold when you suspect you should sell. But you're married to it. I sold today. Glad to leave you guys some scraps on the table.



To: Dr. John M. de Castro who wrote (157)2/4/1998 7:23:00 AM
From: Henry Niman  Respond to of 399
 
Yesterday CNBC discussed a merger combination between AHP and MTC's Searle:
techstocks.com
CNBC also talked about the impact of mergers on Biotechs. Details in the CNBC section of the GLX/AHP/SBH merger table at home.att.net